TAMRA OGILVIE

Title	Professor
Institution	Baylor College of Medicine
Department	Department of Pediatrics
Address	1102 BATES Houston, TX 77030
ORCID	0000-0002-5469-0559
vCard	Download vCard

Bibliographic

selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Borlase S, DeCarlo A, Liang L, Porter CJ, Ramaswamy V, Werbowetski-Ogilvie TE, Coudi?re-Morrison L. Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression. Cell Death Discov. 2023 Sep 19; 9(1):347. PMID: 37726268; PMCID: PMC10509237.

Citations:
Martell E, Kuzmychova H, Kaul E, Senthil H, Chowdhury SR, Fresnoza A, Zagozewski J, Venugopal C, Anderson CM, Singh SK, Banerji V, Werbowetski-Ogilvie TE, Sharif T, Morrison LC. Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma. Nat Commun. 2023 05 02; 14(1):2502. PMID: 37130865; PMCID: PMC10154337.

Citations: Fields:
Bio Biology Sci Science
Translation:Animals
Hendrikse LD, Haldipur P, Saulnier O, Millman J, Sjoboen AH, Erickson AW, Ong W, Gordon V, Shokouhian M, Ly M, Borlase S, Scott DS, Vladoiu MC, Farooq H, Sirbu O, Nakashima T, Nambu S, Funakoshi Y, Bahcheli A, Diaz-Mejia JJ, Golser J, Bach K, Phuong-Bao T, Skowron P, Wang EY, Kumar SA, Balin P, Visvanathan A, Lee JJY, Ayoub R, Chen X, Chen X, Mungall KL, Luu B, Wang YC, Pfister SM, Kim SK, Delattre O, Bourdeaut F, Masliah-Planchon J, Grajkowska WA, Loukides J, Dirks P, French PJ, Kros JM, Zitterbart K, Bailey SD, Eberhart CG, Rao AAN, Giannini C, Olson JM, Hauser P, Phillips JJ, Ra YS, Li KKW, Ng HK, Poon WS, Pollack IF, Gillespie GY, Van Meter TE, Shofuda T, Vibhakar R, Thompson RC, Cooper MK, Rubin JB, Kumabe T, Jung S, Lach B, Iolascon A, Ferrucci V, de Antonellis P, Zollo M, Cinalli G, Robinson S, Stearns DS, Van Meir EG, Porrati P, Finocchiaro G, Massimino M, Faria CC, Roussel MF, Boop F, Chan JA, Aldinger KA, Silvestri E, McLendon RE, Thompson EM, Ansari M, Garre ML, Chico F, Morrissy AS, Cavalli FMG, Wu X, Daniels C, Rich JN, Jones SJM, Moore RA, Marra MA, Huang X, Sorensen PH, Wechsler-Reya RJ, Weiss WA, Pugh TJ, Garzia L, Kleinman CL, Stein LD, Jabado N, Malkin D, Golden JA, Ellison DW, Doble B, Ramaswamy V, Werbowetski-Ogilvie TE, Suzuki H, Millen KJ, Taylor MD, Coudi?re-Morrison L, Mercier AL, Su?rez RA, B?rub? P, Doz F, F?vre-Montange M, Jouvet A, Garami M, de Torres C, Mora J, L?pez-Aguilar E, Carlotti CG, Razavi F, Egu?a P, P?rezpe?a M, Reimand J, Ayrault O. Failure of human rhombic lip differentiation underlies medulloblastoma formation. Nature. 2022 09; 609(7929):1021-1028. PMID: 36131014; PMCID: PMC10026724.

Citations:
Zagozewski J, Borlase S, Guppy BJ, Shahriary GM, Gordon V, Liang L, Cheng S, Porter CJ, Kelley R, Hawkins C, Chan JA, Liang Y, Gong J, Saulnier O, Wechsler-Reya RJ, Ramaswamy V, Werbowetski-Ogilvie TE, Coudi?re-Morrison L, N?r C. Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression. Commun Biol. 2022 07 14; 5(1):697. PMID: 35835937; PMCID: PMC9283517.

Citations:
Chukwueke UN, Vera E, Acquaye A, Hervey-Jumper SL, Odia Y, Klesse LJ, Dunbar E, Sharma A, Fonkem E, Thomas AA, Werbowetski-Ogilvie TE, Camelo-Piragua S, Gatson NTN, de la Fuente MI, Armstrong TS, Porter AB, Jackson S. SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology. Neuro Oncol. 2021 11 02; 23(11):1845-1858. PMID: 34302487; PMCID: PMC8563326.

Citations:
Werbowetski-Ogilvie TE. From sorting to sequencing in the molecular era: the evolution of the cancer stem cell model in medulloblastoma. FEBS J. 2022 04; 289(7):1765-1778. PMID: 33714236.

Citations:
Zagozewski J, Shahriary GM, Saulnier O, Stromecki M, Fresnoza A, Palidwor G, Porter CJ, Forget A, Ayrault O, Hawkins C, Chan JA, Vladoiu MC, Sundaresan L, Arsenio J, Taylor MD, Ramaswamy V, Werbowetski-Ogilvie TE, Morrison LC. An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate. Nat Commun. 2020 07 20; 11(1):3627. PMID: 32686664; PMCID: PMC7371715.

Citations: 4 Fields:
Bio Biology Sci Science
Translation:Humans Animals Cells
Liang L, Tatari N, Stromecki M, Fresnoza A, Porter CJ, Del Bigio MR, Hawkins C, Chan JA, Ryken TC, Taylor MD, Ramaswamy V, Werbowetski-Ogilvie TE, Coudi?re-Morrison L. CD271+ Cells Are Diagnostic and Prognostic and Exhibit Elevated MAPK Activity in SHH Medulloblastoma. Cancer Res. 2018 08 15; 78(16):4745-4759. PMID: 29930101.

Citations:
Stromecki M, Tatari N, Kaur R, Zagozewski J, Palidwor G, Ramaswamy V, Skowron P, Milde T, Del Bigio MR, Taylor MD, Werbowetski-Ogilvie TE, Morrison LC, W?lfl M. Characterization of a novel OTX2-driven stem cell program in Group 3 and Group 4 medulloblastoma. Mol Oncol. 2018 04; 12(4):495-513. PMID: 29377567; PMCID: PMC5891039.

Citations:

Year	Publications
2018	2
2020	1
2021	2
2022	2
2023	2

OGILVIE's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (61)

Explore

Similar People (60)

Explore

Same Department

Explore